We are live on ! Find out more
XTNT icon

Xtant Medical Holdings
XTNT

25 hedge funds and large institutions have $5.1M invested in Xtant Medical Holdings in 2013 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 1

25% more funds holding

Funds holding: 20 → 25 (+5)

0% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 4

20% less capital invested

Capital invested by funds: $6.39M → $5.1M (-$1.29M)

Holders
25
Holders Change
+5
Holders Change %
+25%
% of All Funds
0.73%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
4
Reduced
4
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
O
OrbiMed
New York
+$799K
2
PCM
Perkins Capital Management
Minnesota
+$142K
3
CCM
Coe Capital Management
Illinois
+$63.6K
4
Renaissance Technologies
Renaissance Technologies
New York
+$25.9K
5
U
UBS
Switzerland
+$13K

Top Sellers

Rank Fund Capital Flow
1
GCM
Goldman Capital Management
New York
-$495K
2
DM
Deerfield Management
New York
-$202K
3
Deutsche Bank
Deutsche Bank
Germany
-$6K
4
OA
Outfitter Advisors
Virginia
-$5.37K
5
Morgan Stanley
Morgan Stanley
New York
-$511
Name Holding Trade Value Shares
Change 		Change in
Stake
O
1
OrbiMed
New York
$1.63M +$799K +12,500 +85%
PCM
2
Perkins Capital Management
Minnesota
$1.48M +$142K +2,223 +10%
GCM
3
Goldman Capital Management
New York
$788K -$495K -7,741 -37%
OA
4
Outfitter Advisors
Virginia
$392K -$5.37K -84 -1%
Vanguard Group
5
Vanguard Group
Pennsylvania
$296K – – –
DM
6
Deerfield Management
New York
$196K -$202K -3,166 -49%
CCM
7
Coe Capital Management
Illinois
$60K +$63.6K +996 New
California Public Employees Retirement System
8
California Public Employees Retirement System
California
$49K – – –
Geode Capital Management
9
Geode Capital Management
Massachusetts
$41K – – –
LPL Financial
10
LPL Financial
California
$40K – – –
Renaissance Technologies
11
Renaissance Technologies
New York
$32K +$25.9K +406 +317%
U
12
UBS
Switzerland
$23K +$13K +204 +117%
Northern Trust
13
Northern Trust
Illinois
$20K – – –
VWM
14
Valley Wealth Managers
New Jersey
$18K – – –
Citadel Advisors
15
Citadel Advisors
Florida
$9K +$9.84K +154 New
Morgan Stanley
16
Morgan Stanley
New York
$6K -$511 -8 -8%
VKH
17
Virtu KCG Holdings
New York
$6K +$6.84K +107 New
GI
18
Gradient Investments
Minnesota
$5K – – –
RG
19
Rathbones Group
United Kingdom
$5K – – –
State Street
20
State Street
Massachusetts
$5K – – –
PAS
21
Partnervest Advisory Services
California
$1K +$1.09K +17 New
BNP Paribas Financial Markets
22
BNP Paribas Financial Markets
France
$603 +$639 +10 New
Deutsche Bank
23
Deutsche Bank
Germany
– -$6K -82 Closed
Bank of America
24
Bank of America
North Carolina
– +$64 +1 New

XTNT Hedge Fund Activity: Q4 2013 in Review

25 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Xtant Medical Holdings (XTNT) for Q4 2013, worth a combined $5.1M — down 20% from $6.39M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new XTNT positions and 1 closed out — a net gain of 5 holders — while 4 added to existing stakes and 4 trimmed.

The largest buyer was OrbiMed, adding an estimated $799K. The largest seller was Goldman Capital Management, cutting an estimated $495K.

  • 25 institutional investors held Xtant Medical Holdings (XTNT) as of Q4 2013, up from 20 in Q3 2013.
  • Funds reported $5.1M of Xtant Medical Holdings stock for Q4 2013, down 20% quarter-over-quarter.
  • 6 funds opened new Xtant Medical Holdings positions in Q4 2013 and 1 closed out, a net change of +5 holders.
  • The largest Xtant Medical Holdings buyer in Q4 2013 was OrbiMed, an estimated $799K added.
  • The largest Xtant Medical Holdings seller in Q4 2013 was Goldman Capital Management, an estimated $495K sold.

Based on aggregated 13F filings for Q4 2013.